Skip to main content
Chemomab Therapeutics Ltd. logo

Chemomab Therapeutics Ltd. — Investor Relations & Filings

Ticker · CMMB ISIN · US16385C1045 US Manufacturing
Open in API
Filings indexed 332 across all filing types
Latest filing 2018-10-25 Regulatory Filings
Country US United States of America
Listing US CMMB

About Chemomab Therapeutics Ltd.

https://www.chemomab.com/

Chemomab Therapeutics Ltd. is a clinical-stage biotechnology company developing therapeutics for fibro-inflammatory diseases with high unmet medical needs. The company's scientific platform is based on the discovery of the soluble protein CCL24's central role in driving the cycle of fibrosis and inflammation. Its lead product candidate, nebokitug (CM-101), is a first-in-class monoclonal antibody designed to neutralize CCL24, thereby interfering with the primary pathways that promote these conditions. Nebokitug has demonstrated disease-modifying potential in multiple clinical trials and has received Orphan Drug and Fast Track designations from the U.S. FDA for the treatment of primary sclerosing cholangitis (PSC). Following positive Phase 2 results, the company is preparing for a potential Phase 3 trial for nebokitug in PSC.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2018
Regulatory Filings
2018-10-25 English
Capital/Financing Update 2018
Capital/Financing Update Classification · 95% confidence The document is a Form F-1 Registration Statement filed with the U.S. Securities and Exchange Commission (SEC) under the Securities Act of 1933. It is a preliminary prospectus for an initial public offering (IPO) of American Depositary Shares (ADSs) by Anchiano Therapeutics Ltd. The document includes detailed information about the company, the offering, risk factors, use of proceeds, management discussion and analysis, financial data, and other disclosures typical of an IPO registration statement. This type of filing is a capital markets document related to fundraising and securities registration, not a financial report, earnings release, or management report. Therefore, it fits best under the category of Capital/Financing Update (CAP).
2018-09-28 English
Capital/Financing Update 2015
Capital/Financing Update Classification · 100% confidence The document is a Form F-1 Registration Statement filed confidentially with the SEC, related to an initial public offering (IPO) of American Depositary Shares (ADSs) by BioCancell Ltd. It includes a preliminary prospectus with detailed information about the company, its business, financial data, risk factors, management discussion and analysis, and other disclosures typical of an IPO registration statement. This type of filing is a registration statement under the Securities Act of 1933, used to register securities for public sale. It is not an annual report, earnings release, or any other report type listed. The document is a primary registration filing for capital raising and public offering, which fits the Capital/Financing Update (CAP) category best, as it relates to company fundraising and capital structure changes through an IPO.
2015-11-03 English
Capital/Financing Update 2015
Capital/Financing Update Classification · 100% confidence The document is a Form F-1 Registration Statement filed with the SEC, which is used for initial public offerings (IPOs) of securities. It includes a preliminary prospectus with detailed information about the company, its business, financial data, risk factors, management discussion, and other disclosures required for an IPO. This type of filing is a capital markets document related to the company's fundraising and securities registration. It is not an annual report, earnings release, or any other type of report but specifically a registration statement for a public offering under the Securities Act of 1933. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length and content confirm it is a full registration statement, not just an announcement or a brief notice.
2015-09-22 English
20-F
Annual Report FY 2012
2013-04-23 English
SC 13D/A
Major Shareholding Notification
2013-01-08 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.